HeyJaredOren Rice
- Indexed articles, last 90 days
- 5
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Ynetnews
- Top 50K sites
- Earliest in this view
- Sep 2, 2026
Latest articles
Battle of the weight-loss shots: Which one works best? (opens the original)
Read excerpt
The European Association for the Study of Diabetes (EASD) conference in Milan, Italy, turned into a heated boxing ring between pharmaceutical giants Novo Nordisk and Eli Lilly, makers of weight-loss injections and pills. Within a matter of hours, the companies released studies and statements touting the advantages of their products over their rivals.Eli Lilly said Mounjaro produced greater weight loss than Wegovy. It also said its new weight-loss pill, orforglipron, marketed as Foundayo, deliver
Greek singer dies during anti-aging treatment as doctors allegedly turn to ChatGPT for CPR (opens the original)
Read excerpt
Yorgos Mazonakis, one of Greece’s most popular singers of the past three decades, arrived at a private clinic in Athens on Sept. 9 for a scheduled plasma exchange treatment. Hours later, the 54-year-old was dead.Nearly three weeks later, what initially appeared to be a sudden medical death has become a criminal investigation dominating headlines in Greece and Cyprus. Among the most startling details reported by Greek television channel MEGA is that investigators examining the treating doctor’s p
Weekly insulin is coming to Israel — with a rival close behind (opens the original)
Read excerpt
People with type 2 diabetes who are treated with insulin know the routine well: at least one injection every day, without a break.On Thursday, the U.S. Food and Drug Administration approved Eli Lilly’s Onswik, a long-acting insulin injected just once a week. The drug is intended for adults, alongside an appropriate diet and exercise, and according to the company it could spare patients more than 300 injections a year.Onswik is not the first of its kind. It is the second once-weekly insulin appro
Even dim bedroom light may harm your heart, MRI study finds (opens the original)
Read excerpt
A tiny LED on an electronic device, streetlight filtering through the blinds, an alarm clock glowing green on the nightstand. Light sources that seem too insignificant to cause harm, and that many of us sleep beside without a second thought, have emerged in a new study as something the heart can clearly sense. This time, in one of the first studies of its kind, researchers did not simply count cardiovascular events. They looked directly at the heart itself using MRI scans and found that it chang
Teva celiac drug protects gut from gluten damage after single injection in trial (opens the original)
Read excerpt
An experimental celiac disease drug developed by Teva significantly reduced gluten-induced damage to the small intestine after a single injection, according to positive topline results from an ongoing Phase 2a trial released Wednesday.The investigational antibody, TEV ‘408, met the study’s primary endpoint by showing statistically significant and clinically meaningful protection against intestinal damage compared with placebo. Teva said the treatment was well tolerated and that no safety signals
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Ynetnews, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.